| TRT | Targeted Radionuclide Therapy |
| LET | Linear Energy Transfer |
| PRRT | Peptide Receptor Radionuclide Therapy |
| SSTR | Somatostatin Receptor |
| PSMA | Prostate-Specific Membrane Antigen |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| EGFR | Epidermal Growth Factor Receptor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| NET | Norepinephrine Transporter |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| TNBC | Triple-Negative Breast Cancer |
| GEP-NENs | Gastroenteropancreatic Neuroendocrine Neoplasms |
| GBM | Glioblastoma Multiforme |
| MDS | Myelodysplastic Syndromes |
| PFS | Progression-Free Survival |
| ICD | Immunogenic Cell Death |
| DOTA | 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| DTPA | Diethylenetriaminepentaacetic acid |
| NOTA | 1,4,7-Triazacyclononane-1,4,7-triacetic acid |
| HEHA | Hexaazacyclohexadecane-N,N′,N′′,N′′′,N′′′′,N′′′′′-hexaacetic acid |
| EDTA | Ethylenediaminetetraacetic acid |
| CHX-DT | Cyclohexyl-diethylenetriaminepentaacetic acid |
| PA | |
| PEPA | p-isothiocyanatobenzyl-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic acid |
| DOTP | 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid |
| LPy | Lipoyl-Pyridine |
| Macropa | Macrocyclic Pyridinophane |
| SPECT | Single-Photon Emission Computed Tomography |
| PET | Positron Emission Tomography |
| MRI | Magnetic Resonance Imaging |
| PAI | Photoacoustic Imaging |
| PTT | Photothermal Therapy |
| PDT | Photodynamic Therapy |
| RBE | Relative Biological Effectiveness |
| RCY | Radiochemical Yield |
| BFC | Bifunctional Chelator |
| scFv | Single-Chain Variable Fragment |
| mAb | Monoclonal Antibody |
| F(ab′)2 | Fragment antigen-binding |
| sdAb | Single-Domain Antibody |
| EV | Extracellular Vesicle |
| AuNPs | Gold Nanoparticles |
| PIONs | Porous Iron Oxide Nanoparticles |
| MPDA | Mesoporous Polydopamine |
| SWNT | Single-Walled Carbon Nanotube |
| PEG | Polyethylene Glycol |
| iRGD | Internalizing RGD |
| NK-1 | Neurokinin-1 |
| MC1-R | Melanocortin 1 Receptor |
| S1R | Sigma-1 Receptor |
| GRPR | Gastrin-Releasing Peptide Receptor |
| PSCA | Prostate Stem Cell Antigen |
| DLL3 | Delta-Like Ligand 3 |
| FRα | Folate Receptor Alpha |
| CD133 | Cluster of Differentiation 133 |
| αvβ3 | Integrin Alpha-V Beta-3 |
| DAMPs | Damage-Associated Molecular Patterns |
| FDA | Food and Drug Administration |
| AI | Artificial Intelligence |
| SIRT | Selective Internal Radiation Therapy |
| PMMA | Polymethylmethacrylate |
| EBRT | External Beam Radiation Therapy |
| SELEX | Systematic Evolution of Ligands by Exponential Enrichment |